Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_assertion type Assertion NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_head.
- NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_assertion description "[In the cases of CLU, PICALM and CR1, as well as in APOE, the odds ratios we find are slightly larger than those previously reported in clinical samples, consistent with what we believe to be more accurate classification of disease in the clinically characterized and neuropathologically confirmed AD cases and controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_provenance.
- NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_assertion evidence source_evidence_literature NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_provenance.
- NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_assertion SIO_000772 20534741 NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_provenance.
- NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_assertion wasDerivedFrom befree-20140225 NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_provenance.
- NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_assertion wasGeneratedBy ECO_0000203 NP209374.RA-lllGSc5xa_sKlPpqcxgXN-EJd_Buchnlzk87rrNvro130_provenance.